Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.200 | 5 | 96776379 | 3 prime UTR variant | T/A;G | snv | 3.3E-05; 0.26 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Stomatognathic Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
5 | 96740769 | missense variant | C/T | snv | 4.0E-06 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.040 | 5 | 96710335 | intron variant | A/C;G | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.120 | 5 | 96700607 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
1.000 | 0.120 | 5 | 96700607 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
1.000 | 0.120 | 5 | 96700607 | intron variant | G/A;C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
5 | 96741291 | missense variant | T/C | snv | 1.2E-05 |
|
Pathological Conditions, Signs and Symptoms; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
5 | 96765222 | splice acceptor variant | A/G;T | snv | 8.1E-06 |
|
Pathological Conditions, Signs and Symptoms; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
5 | 96747369 | missense variant | C/A;T | snv | 6.4E-05; 2.4E-04 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
5 | 96762316 | missense variant | G/A | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 0.040 | 5 | 96765321 | missense variant | T/A;C | snv | 7.1E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 5 | 96762313 | frameshift variant | G/- | del |
|
0.710 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
1.000 | 5 | 96729723 | stop gained | A/T | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 5 | 96737877 | frameshift variant | -/A | delins |
|
0.700 | 0 | |||||||||||||
|
5 | 96746364 | missense variant | T/C | snv | 7.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
5 | 96741548 | missense variant | C/G;T | snv | 4.0E-06 | 7.0E-06 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
5 | 96742749 | missense variant | T/C | snv | 7.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
1.000 | 0.080 | 5 | 96737892 | missense variant | G/C | snv | 4.0E-05 | 7.0E-06 |
|
Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
5 | 96746417 | missense variant | C/T | snv | 2.0E-05 | 3.5E-05 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.040 | 5 | 96742998 | intron variant | A/G | snv | 9.4E-02 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.040 | 5 | 96742998 | intron variant | A/G | snv | 9.4E-02 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
5 | 96745179 | intron variant | A/G | snv | 0.27 |
|
0.700 | 1.000 | 2 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 5 | 96760515 | intron variant | C/G | snv | 0.29 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 5 | 96761124 | 3 prime UTR variant | A/G | snv | 0.35 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 5 | 96762510 | 3 prime UTR variant | G/A | snv | 0.36 |
|
Musculoskeletal Diseases | 0.020 | 1.000 | 2 | 2014 | 2016 |